The global orthopedic device and instrumentation market is witnessing unprecedented shifts. Rising surgical volumes, driven by an aging demographic and active lifestyles, demand highly reliable structural solutions. Modern orthopedic surgeons and clinical managers seek instrumentation that reduces intraoperative errors, minimizes surgical steps, and ensures optimal biomechanical outcomes.
As a leading orthopedic instrument manufacturer and exporter, Synoviq Medical Technology (China) Co., Ltd. addresses these demands through advanced structural engineering. By utilizing medical-grade Titanium alloys (Ti-6Al-4V ELI) and implantable PEEK materials, our products achieve a balance between mechanical durability and biocompatibility.
From trauma fixation systems to complex spinal implants, we align our product portfolio with international clinical needs, lowering the risk of hardware failure and implant rejection while optimizing overall healthcare costs.
Eliminating structural risks through advanced medical-grade alloy configurations and surface treatments.
Streamlining operating room procedures with ergonomically designed spinal and trauma kits.
Synoviq Medical Technology (China) Co., Ltd. is a professional manufacturer of orthopedic implants and surgical instruments, dedicated to delivering innovative, reliable, and high-quality medical solutions for healthcare professionals worldwide. Since its establishment, Synoviq has focused on research, development, precision manufacturing, and international quality standards, providing comprehensive OEM and ODM services for global medical device brands, distributors, and hospitals.
Our product portfolio includes trauma fixation systems, spinal implants, locking plates, intramedullary nails, external fixation systems, orthopedic screws, surgical instruments, and customized orthopedic solutions. Equipped with advanced CNC machining centers, precision inspection equipment, and modern clean production facilities, we ensure every product meets strict international quality requirements.
Driven by continuous innovation, Synoviq invests heavily in R&D and intelligent manufacturing to enhance product performance, surgical efficiency, and patient outcomes. Our experienced engineering team works closely with customers to develop customized products tailored to different clinical applications and market demands.
With a customer-oriented philosophy, competitive pricing, stable supply capability, and efficient technical support, Synoviq has established long-term partnerships with distributors, medical brands, and healthcare organizations across Europe, North America, South America, the Middle East, and Asia-Pacific.
| Key Operational Indicators | Enterprise Specifications & Data |
|---|---|
| Company Name | Synoviq Medical Technology (China) Co., Ltd. |
| Brand | Synoviq |
| Established | March 18, 2016 |
| Building Area | 18,600 m² |
| Annual Export Revenue | USD 21.8 Million |
| Export Experience | 8 Years |
| Industry Experience | 14 Years |
| Quality Inspection | 100% Final Inspection & Incoming Material Inspection |
| Product Inspection Methods | CMM Measurement, Mechanical Testing, Surface Roughness Testing, Hardness Testing, Salt Spray Testing, Sterility Validation |
| Quality Control Staff | 48 |
| Business Type | Manufacturer & Exporter (OEM/ODM) |
| Main Markets | Europe, North America, South America, Middle East, Southeast Asia |
| Supply Chain Partners | 1,120+ |
| R&D Capability | Independent Product Design, Prototype Development, Clinical-Oriented Engineering, OEM & ODM Development |
| Customization Options | Logo, Packaging, Product Design, Material Selection, Surface Treatment |
| New Products Released Last Year | 186 |
| R&D Engineers | 76 |
Navigating the transition from MDD to MDR in Europe and satisfying FDA 510(k) requirements in the United States requires comprehensive documentation. Our engineering systems maintain full traceability, including material melt certificates, CNC verification logs, and sterile barrier testing protocols. This documentation supports the registration process for local distributors and importers.
Large-scale hospital tenders and regional distributors require predictable lead times and stock availability. With over 1,120 supply chain partners and USD 21.8 million in annual export operations, we mitigate supply chain volatility. Our logistical systems are structured to minimize delays for critical orthopedic instrumentation.
Orthopedic procedures vary by region in terms of sizing preferences, instrument grip design, and material selections. Our R&D department customized 186 new products last year, tailoring locking plate profiles, cannulated screw pitches, and target guides to align with localized surgical practices across North America, Latin America, Europe, and the Asia-Pacific region.
Modern clinical studies highlight the role of implant surface topology in osteointegration. Synoviq is developing bioactive porous titanium structures that mimic human trabecular bone. These structures encourage cell migration and bone ingrowth, improving long-term implant stability.
Our research focuses on reducing patient incision sizes and soft-tissue disruption. The Geasure MIS Percutaneous Screw system features low-profile designs and guided insertion mechanisms, helping surgical teams achieve stable fixation with minimal tissue damage.
Through our digital design and prototyping capabilities, we support patient-specific implant (PSI) creation. By utilizing CT reconstruction and 3D printing technologies, we fabricate customized jigs and implants that match patient anatomy, addressing complex oncological or reconstructive cases.
Every production batch undergoes comprehensive mechanical and material verification to ensure reliability under physiological loads.
Synoviq Medical